Partnered with ICI World of Journals.
DOI is provided by the Crossref and all the manuscripts will be indexed in Crossref
1.1. Objective: Qianliexin Capsule (QLX), a traditional Chinese medicine, has been widely used to treat Chronic Nonbacterial Prostatitis (CNP) in China. Here, metabolic profiling was utilized to clarify the bio-targets of QLX in CNP treatment.
No Data Available